Top broker tips Allkem (ASX:AKE) share price to shoot 20% higher

Allkem could be a lithium share to buy according to one leading broker…

| More on:
A group of stockbrokers sit in a room with several computer screens in front of them as they discuss the Zip share price and Zip's merger with Sezzle

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Allkem has been upgraded to a buy rating by analysts at Morgans
  • The broker sees 20% upside from current levels
  • Allkem is the broker's top pick in the sector

The Allkem Ltd (ASX: AKE) share price is pushing higher again on Thursday.

In afternoon trade, the lithium miner's shares are up 2% to $11.03.

This means the Allkem share price is now up 93% over the last 12 months.

Why is the Allkem share price pushing higher today?

The catalyst for the rise in the Allkem share price on Thursday has been a broker note out of Morgans this morning.

According to the note, the broker has upgraded the company's shares to an add rating and lifted its price target on them to $13.25.

Based on the current Allkem share price, this implies potential upside of 20% over the next 12 months.

What did the broker say?

Morgans has been looking at the lithium sector and notes that spot lithium prices have hit new records and are putting pressure on contract prices.

Its preferred pick for lithium exposure is Allkem. This is due to its near term exposure sky high prices for the battery making ingredient and its long production growth runway.

The broker said: "Our preferred stock for lithium exposure, Allkem (AKE). AKE announced a 68% qoq increase in revenue at Olaroz and a 7% CY21 beat of production guidance at Mt Cattlin with large increases in realised prices at both projects. AKE expects USD20k/t for lithium carbonate sales in 2HFY22 at Olaroz. Production growth continues with Naraha commissioning, progress on Sal de Vida and FID expected on James Bay in 2QCY22. Construction is expected to commence the following quarter."

All in all, this could make Allkem a lithium share to buy in 2022 according to the team at Morgans.

Motley Fool contributor James Mickleboro owns Orocobre Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Man pointing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Morgans says these ASX 200 stocks can rise 30%

Big returns could be on the cards for buyers of these shares.

Read more »

Successful group of people applauding in a business meeting and looking very happy.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A group of stockbrokers sit in a room with several computer screens in front of them as they discuss the Zip share price and Zip's merger with Sezzle
Broker Notes

Here are the latest broker rating changes on 3 prominent ASX shares

Brokers have delivered a mixed bag this week.

Read more »

Two people climb to the summit and raise their arms in success as the sun rises brightly over the mountains.
Financial Shares

'Strong momentum': 2 ASX financial shares backed by top fundie for 2025

ASX financial shares had a strong trading session on Tuesday with several new price records set.

Read more »

Person holding Australian dollar notes, symbolising dividends.
Broker Notes

The best Australian shares to buy with $7,000 right now

Analysts think these shares could give you a good return on investment.

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Broker Notes

Top broker says buy ResMed and this ASX 200 share

Ord Minnett was impressed with their quarterly updates from last month.

Read more »

A young woman makes an online travel booking as she sits on some steps with her suitcase next to her.
Broker Notes

2 ASX All Ords shares just upgraded by top brokers (one with 44% upside!)

Leading brokers forecast some outsized gains ahead for these two ASX All Ords shares.

Read more »

Two smiling work colleagues discuss an investment or business plan at their office.
Broker Notes

Guess which ASX 200 share Goldman Sachs says is a buy

Let's see which stock is being tipped as a buy by analysts.

Read more »